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GermanyABSTRACT Homeostatic mechanisms are essential for the protection and adaptation of organisms in a changing and chal-
lenging environment. Previously, we have described molecular mechanisms that lead to robust homeostasis/adaptation under
inﬂow or outﬂow perturbations. Here we report that harmonic oscillations occur in models of such homeostatic controllers and that
a close relationship exists between the control of the p53/Mdm2 system and that of a homeostatic inﬂow controller. This homeo-
static control model of the p53 system provides an explanation why large ﬂuctuations in the amplitude of p53/Mdm2 oscillations
may arise as part of the homeostatic regulation of p53 by Mdm2 under DNA-damaging conditions. In the presence of DNA
damage p53 is upregulated, but is subject to a tight control by Mdm2 and other factors to avoid a premature apoptotic response
of the cell at low DNA damage levels. One of the regulatory steps is the Mdm2-mediated degradation of p53 by the proteasome.
Oscillations in the p53/Mdm2 system are considered to be part of a mechanism by which a cell decides between cell cycle arrest/
DNA repair and apoptosis. In the homeostatic inﬂow control model, harmonic oscillations in p53/Mdm2 levels arise when the
binding strength of p53 to degradation complexes increases. Due to the harmonic character of the oscillations rapid ﬂuctuating
noise can lead, as experimentally observed, to large variations in the amplitude of the oscillation but not in their period, a behavior
which has been difﬁcult to simulate by deterministic limit-cycle models. In conclusion, the oscillatory response of homeostatic
controllers may provide new insights into the origin and role of oscillations observed in homeostatically controlled molecular
networks.INTRODUCTIONMechanisms that maintain robust homeostasis in genetic and
biochemical networks are essential for the fitness of organ-
isms in a changing and challenging environment (1). Many
physiologically important variables are under tight homeo-
static control, where internal concentrations or fluxes are
maintained at well-defined levels despite environmental
perturbations. Such perfect adaptation/homeostasis (2) has
been found, for example, in bacterial chemotaxis (3–6),
photoreceptor responses (7), and MAP-kinase regulation
(8–10). Drengstig et al. (11) have recently shown how perfect
adaptation motifs may be identified in reaction kinetic
networks.
Although perfect homeostasis can be related to the control-
theoretic concepts of integral feedback or integral control
(12,13), it has recently been shown that, in reaction kinetic
terms, perfect homeostasis is closely connected to the pres-
ence of a zero-order flux (14), which controls another control-
ling agent (i.e., control of the controller). The latter is
responsible for the removal or synthesis of a homeostatically
regulated intermediate. Fig. 1 shows two controller motifs
fromNi et al. (14), in which intermediate A is homeostatically
regulated. Fig. 1 a presents an inflow controller, where the
control mechanism can compensate for large in-flow pertur-
bations of A, and Fig. 1 b presents an outflow-controller,Submitted August 15, 2009, and accepted for publication November 11,
2009.
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0006-3495/10/03/0743/10 $2.00where A shows homeostasis when A is subject to large
fluctuations in its removal. It should be noted that these
control schemes will generally fail, when large outflows
occur in inflow controllers or large inflows occur in outflow
controllers (14).
Here, we demonstrate that the two homeostatic controllers
in Fig. 1 can show damped or practically undamped large
amplitude harmonic oscillations. The degree of damping
depends on the binding characteristics between the controller
Eadapt and A, as well as on the synthesis and removal of the
homeostatically controlled intermediate A. To our knowl-
edge, this is the first example that describes large amplitude
harmonic oscillations in a biochemical oscillator model (see
the recent review on design principles of biochemical oscil-
lators (15)).
Interestingly, the controller in Fig. 1 a shows high simi-
larity to the feedback control of p53 by Mdm2, when A is
taken as p53, Eadapt as Mdm2, and Etr as the class of
Mdm2-independent proteasomal degradation reactions of
p53 (16–21). In the presence of DNA damage, p53 is upre-
gulated by slowing down its various degradation reactions,
but still requires a tight control to avoid premature apoptosis
by high levels of p53 (22,23). We propose the idea that this
control is mediated by Mdm2 and related factors by means of
a homeostatic inflow mechanism, which maintains a level of
p53 in a state of indecisiveness, until a final decision between
cell cycle arrest/DNA repair and apoptosis is made (24).
Oscillations in p53/Mdm2 (25,26) may participate in making
this decision. In the proposed inflow model, harmonicdoi: 10.1016/j.bpj.2009.11.013
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FIGURE 1 Schemes of inflow (a) and outflow (b) homeostatic controllers
in which component A shows robust homeostasis against environmentally
uncontrolled perturbations in the inflow and outflow of A (14). Eadapt repre-
sents an enzyme important in the adaptation/homeostasis of A, Etr represents
one or several enzymes important in transforming/removing A, and ksynth is
a rate constant associated with the synthesis of A. Thick solid arrows with
kpert indicate where in the controller inflow or outflow perturbations occur.
For a more detailed discussion of these schemes, see Ni et al. (14).
744 Jolma et al.oscillations in p53 and Mdm2 can occur when p53 binds
strongly to the Mdm2-induced degradation machinery,
where p53 oscillates around the level defined by the homeo-
static controller. Due to the harmonic character of the oscil-
lation, rapid molecular noise leads to large variations in the
p53/Mdm2 amplitude whereas the period is only little
affected—a behavior that has been experimentally observed
(27) but which is difficult to reproduce by deterministic
limit-cycle models (27,28). Large fluctuating amplitudesBiophysical Journal 98(5) 743–752in the p53/Mdm2 oscillations seem to be of importance in
determining cell fate (26,27), as will be discussed in more
detail below. Thus, a homeostatic inflow model provides
an integrative view on the negative feedback regulation
of p53 and the appearance of oscillations. Such a view
may also provide new insights into the origin and role of
oscillations observed in homeostatically controlled molec-
ular networks.
Harmonic oscillations in perfect controllers
A possible kinetic representation for the inflow-controller
scheme of Fig. 1 a can be given by
dA
dt
¼ kpert þ ksynth  k$EadaptAn  V
Etr
maxA
KEtrM þ A
; (1)
dEadapt
dt
¼ kadaptA V
Eset
maxEadapt
KEsetM þ Eadapt
; (2)
where VEimax ¼ kEicatEtoti with kEicat and Eitot is the turnover
number and total concentration of enzyme species i, respec-
tively. The n is the reaction order with respect to A in the
removal of A by Eadapt. With respect to the discussion that
will follow below, it may be noted that zero-order kinetics
with respect to A (n ¼ 0 in Eq. 1) may be obtained by
k$Eadapt$A
K
Eadapt
M þ A
/k$Eadapt; (3)
when K
Eadapt
M  A. In terms of a rapid equilibrium model
of the Michaelis-Menten equation, small K
Eadapt
M values can
be interpreted as a strong affinity between substrate A and
Eadapt.
The set-point for homeostatic regulation in A is determined
by setting Eq. 2 to zero and demanding that the controller
Eadapt is removed by another control species (Eset) under
zero-order conditions. This requires that KEsetM  Eadapt,
which gives the homeostatic set-pointAset forA at steady-state
conditions (14):
Aset ¼ V
Eset
max
kadapt
¼ k
Eset
cat E
tot
set
kadapt
: (4)
A is robustly regulated as long as the right-hand term of
Eq. 4 remains practically constant and as long the degrada-
tion in A is not dominating with respect to the influxes kpert
and ksynth. In Eq. 2, the removal of Eadapt by Eset using
Michaelis-Menten kinetics also ensures that, even at low
KEsetM values, Eadapt does not become negative, as it sometimes
would if the Aset term ðVEsetmaxEadaptÞ=ðKEsetM þ EadaptÞwere to be
replaced by a true constant (14).
An interesting aspect is that oscillations emerge in the
controller when the reaction order becomes zero with respect
to A. Fig. 2 illustrates this behavior by applying a stepwise
change in kpert (from 1.0 to 2.0) when the system is initially
at a steady state at first and zero reaction orders with
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FIGURE 2 Generation of harmonic oscillations for the
homeostatic controller in Fig. 1 a by decreasing reaction
order n with respect to A. Rate constant values are kpert ¼
1.0, kadapt ¼ 3.0, kEsetcat ¼ 6  106, KEsetM ¼ 1  106,
ksynth ¼ 1:0, kEtrcat ¼ 1  102, and KEtrM ¼ 1  102 with
Aset ¼ 1.0. The reaction orders n with respect to A are (a)
1.0; (b) 1  101; (c) 1  102; and (d) 0.0. At time t ¼
10.0 a.u., kpert is increased from 1.0 to 2.0 and the system
approaches a new steady state. Note that A shows robust
homeostasis with Aset ¼ 1.0. With decreasing n values
harmonic oscillations are emerging where A oscillates
around Aset with a peak amplitude approaching Aset as
n approaches zero.
Oscillations in Homeostatic Controllers 745respect to A. By using the rate constant values described in
Fig. 2 such that the term VEtrmaxA=ðKEtrM þ AÞ in Eq. 1 can be
neglected and assuming zero-order kinetics with respect to
A, we can approximate Eqs. 1 and 2 by Eq. 5,
€A
k$kadapt
þ A ¼ Aset; (5)
which leads to undamped harmonic oscillations in A and
Eadapt with a period length P ¼ 2p/(k $ kadapt).
A kinetic representation of the outflow control scheme of
Fig. 1 b can be described as
dA
dt
¼ ksynth þ k$Eadapt  V
Etr
maxA
KEtrM þ A
; (6)
dEadapt
dt
¼ j0  V
Eset
maxEadaptA
KEsetM þ Eadapt
: (7)
In this formulation, the controller shows an oscillatory
response in A and Eadapt for moderate ksynth values and for
low values in KEtrM and K
Eset
M , i.e., having a zero-order degra-
dation of A in Eq. 6 and a first-order degradation rate of Eadapt
with respect to A in Eq. 7. In the following we will focus on
the inflow controller scheme of Fig. 1 a as a simple model for
the p53 regulatory system and its oscillatory behavior.Regulation of p53
The p53 system is one of the most complex regulatory
networks known (22,24,29–35). It is involved in the controlof cell cycle, senescence, DNA repair, apoptosis, and the
prevention of tumor development. More than half of all
human tumors contain mutations of the p53 gene and in
almost all tumors the p53 regulatory circuit is nonfunctional
(31,32). Normally (i.e., in the absence of DNA damaging
conditions), p53 levels are low due to a rapid degradation
by ubiquitin-dependent and ubiquitin-independent pathways
with an approximate p53 half-life between 6 and 30 min
(16–21,36,37). An important regulator of p53 is Mdm2, an
E3 (ubiquitin) ligase for p53 and other tumor suppressors
(38,39). p53 activates the transcription of Mdm2, which
binds p53 (40), ubiquitinates it, and thus initiates the protea-
somal degradation of p53 both in the nucleus and cytosol
(41). This is the central autoregulatory (negative) feedback
loop of p53 (29,32). In the presence of DNA damage or
oxidative stress, p53 is upregulated by several mechanisms
that inhibit Mdm2 activity (42), increase Mdm2 autodegra-
dation (43), and inhibit p53 degradation (44,45). This leads
either to cell cycle arrest and DNA repair at lower DNA
damage, or to the induction of programmed cell death
(apoptosis) at higher DNA damage (24,46,47).
Interestingly, in the presence of high DNA damage, p53
and Mdm2 have been found to oscillate (25–27,48–50).
The origin and purpose of these oscillations is little under-
stood, but may be of considerable interest (26,50,51).
We became interested in the feedback regulation of the p53/
Mdm2 system and its oscillatory response because it shows
a close analogy to the inflow homeostatic control scheme
shown in Fig. 1 a with A h p53 and Eadapt h Mdm2.
The control scheme suggests that, under DNA-damagingBiophysical Journal 98(5) 743–752
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FIGURE 3 (a) The p53-Mdm2 negative feedback system as a homeostatic
inflow control model. Reactions outlined in black occur in the absence of
DNA damage. Under latter conditions, p53 is considered to be rapidly
removed through Mdm2 and through Mdm2-independent proteasomal
degradation. The Mdm2-independent degradation processes are represented
in the model by Ed with Michaelis-Menten parameters K
Ed
M and k
Ed
cat. Eset
Mdm2
is an enzyme or a class of enzymes involved in the degradation of Mdm2.
When this degradation becomes zero-order with respect to Mdm2, then
p53 shows robust homeostatic regulation to the set-point p53set ¼
ðkEMdm2setcat EMdm2set; totÞ=kMdm2s . However, due to rapid p53 degradation at normal
conditions, p53 levels are well below p53set. In the presence of DNA damage
the degradation of p53 is slowed down and p53 is stabilized. One of the
stabilizing mechanisms involve upregulation of NQO1 (16,19,20). Due to
the zero-order degradation of Mdm2 by Eset
Mdm2, p53 levels are limited
by the set-value p53set (see Fig. 4, a and b). When the removal of p53
induced by Mdm2 becomes zero-order with respect to p53, harmonic oscil-
lations in p53 and Mdm2 are generated (see Fig. 4, c and d). p53* and
Mdm2* represent posttranslational modification species of p53 and Mdm2,
respectively. There is evidence that the modified forms p53* and Mdm2*
do interact much less (30,35). In the model, p53* and Mdm2* are assumed
to be in rapid equilibrium with p53 and Mdm2, respectively. (b) Molecular
mechanism in the Mdm2-mediated degradation which can lead to zero-
order kinetics with respect to p53 and first-order kinetics with respect to
Mdm2. p53 and Mdm2 bind to a protein complex/scaffold C, which leads
to the ubiquitination and degradation in p53. A strong binding of p53 to
the complex (small KA and KBA values) lead to zero-order kinetics with
respect to p53, whereas a relative weak binding of Mdm2 lead to first-order
kinetics with respect to Mdm2. For details, see main text and the Supporting
Material.
746 Jolma et al.conditions, p53 is homeostatically regulated to a certain upper
level defined byMdm2 (and other factors), at which it decides
on the essential cellular functionsmentioned above. This view
is supported by the fact that transgenic mice, which lack both
Mdm2 and p53, grow up normally, whereasmice lacking only
Mdm2 die as embryos, possibly due to the uncontrolled
apoptotic activity of p53 (22,23).
Once p53 is regulated to a high level, harmonic oscilla-
tions can occur when p53 binds strongly to ternary or
multiprotein complexes/scaffolds containing Mdm2 (52–
54), which are involved in the (proteasomal) degradation
of p53. In the presence of rapidly fluctuating molecular
noise, the harmonic character of the p53/Mdm2 oscillations
leads to a large variability in their amplitudes but not in
their frequency, as will be shown below. This property is
difficult to simulate by limit cycle models (28). At normal
conditions, i.e., in the absence of DNA damage, p53 is
rapidly degraded by ubiquitin-dependent and ubiquitin-
independent processes, keeping p53 levels well below its
upper limits.
Fig. 3 a shows an outline of a simple inflow regulatory
circuit for the p53-Mdm2 system. A kinetic representation
of this model can be given by the following equations:
dp53
dt
¼ kp53s 
k
0
C0
KA$KAB
p53$Mdm2
þ KAB
Mdm2
þ KBA
p53
þ 1
 V
Ed
maxp53
KEdM þ p53
 kp53s p53 þ kp53

r p53
; (8)
dMdm2
dt
¼ kMdm2s p53
VEsetmaxMdm2
KEsetM þ Mdm2
 kMdm2s Mdm2
þ kMdm2r Mdm2;
(9)
dp53
dt
¼ kp53s p53 kp53

r p53
  kp53d p53; (10)
dMdm2
dt
¼ kMdm2s Mdm2 kMdm2

r Mdm2
 kMdm2d Mdm2:
(11)
The Mdm2-mediated degradation term in Eq. 8 is based
on a rapid equilibrium among p53, Mdm2, and a protein
complex/scaffold C as illustrated in Fig. 3 b (and described
in more detail in the Supporting Material). C0 denotes the
total concentration of C, and KA, KB, KAB, and KBA are
dissociation (KM) constants. Due to the ‘‘Principle of
Detailed Balance’’ (55), we have KA $ KAB ¼ KB $ KBA.
Low values in the Ki values indicate strong binding and
stable complexes. Zero-order kinetics in p53 can be achieved
by low KA and KBA values, whereas first-order kinetics with
respect to Mdm2 is obtained for relative large KAB values.
Applying these conditions, we getBiophysical Journal 98(5) 743–752
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0
C0
KAKAB
p53$Mdm2
þ KAB
Mdm2
þ KBA
p53
þ 1
/
k
0
C0
KAB
Mdm2 ¼ k$Mdm2:
(12)
In Fig. 3 a, the outline in black shows the functioning of
the system in the absence of DNA damage. p53 is held at
low levels due to degradation through a Mdm2-mediated
ubiquitin-dependence and Mdm2-independent proteasomal
degradations (16–20,36,37).
Under DNA-damaging conditions, p53 is upregulated and
posttranslationally modified. One of the processes that lead
to an increase in p53 is the Mdm2-independent upregulation
of NADH quinone oxidoreductase 1 (NQO1) (16). NQO1
binds to p53 and thereby stabilizes it (56). Both p53 and
Mdm2 undergo posttranslational modifications (22,57),
where phosphorylated and acetylated forms are indicated in
the model by p53* and Mdm2*. These forms interact much
less than unmodified forms of Mdm2 and p53 and thus cause
a stabilization of p53. Due to the decrease in the Mdm2-
independent degradation of p53 under DNA damaging
conditions but due to the presence of the (still operative)
zero-order kinetic degradation of unmodified p53 by unmod-
ifiedMdm2, harmonic oscillations of p53 andMdm2 are initi-
ated, and subsequently propagated to the posttranslationally
modified forms p53* and Mdm2*. In addition, MdmX has
been shown to bind to both Mdm2 and p53, which stabilizes
each of these species (58). In our model, the stabilization of
Mdm2 and p53 byMdmX is lumped together with the forma-
tion of the Mdm2* and p53* species. However, it should be0
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time, a.unoted that MdmX is also present in undamaged cells and
considered to maintain transcriptionally inactive p53 in the
nucleus of these cells (58).
Fig. 4 shows concentration profiles for p53 and Mdm2
using the model Eqs. 8–11 with decreasing rates in the ubiq-
uitin-independent degradation of p53 when the Mdm2-
mediated degradation of p53 is zero-order with respect to
p53. Large degradation rates in p53 through Ed lead to p53
levels well below p53set (Fig. 4 a),
p53set ¼

k
EMdm2set
cat E
Mdm2
set; tot
.
kMdm2s ; (13)
whereas p53 levels become homeostatically regulated
when the Ed-induced degradation becomes sufficiently low
(Fig. 4 b). At even lower Ed-mediated degradation of p53,
damped oscillations appear (Fig. 4 c), where p53 oscillates
around p53set with a peak amplitude, which (in the absence
of noise) cannot exceed p53set (Fig. 4 d).
Amplitude/frequency behavior and inﬂuence
of noise
The damping of the oscillations given by Eqs. 8–11 depends
on several parameters. A strong damping or no oscillatory
response is observed when p53 or the posttranslationally
modified species Mdm2* or p53* are rapidly degraded,
i.e., when rate constants kEdcat, k
p53
d , or k
Mdm2
d are large
compared to the influx of p53. On the other hand, sustained
oscillations are observed when kEdcat, k
p53
d , or k
Mdm2
d are much
lower than the influx of p53 into the controller. When kp53

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FIGURE 4 Generation of harmonic oscillations for the
homeostatic inflow controller of the p53-Mdm2 system by
upregulating p53, i.e., by successively decreasing the kEdcat
value of the Mdm2-independent degradation of p53 (see
Fig. 3 and Eqs. 8–11). Rate constant values (in a.u.) are as
follows: ks
p53 ¼ 3.5, KA $ KAB ¼ 1.0  104, KAB ¼
1.0  102, KBA ¼ 1.0  107, k0 $ C0 ¼ 40.0, ksMdm2 ¼
3.0, k
EMdm2set
cat ¼ 6:0  106, KE
Mdm2
set
M ¼ 1:0  106,
KEdM ¼ 1:0  104, krp53* ¼ 50.0, kdp53* ¼ 0.0,
kr
Mdm2* ¼ 1.0  102, kdMdm2* ¼ 0.0, Eset, totMdm2 ¼ 5.0 
107, Ed, tot ¼ 0.1, and p53set ¼ 1.0. (a) High values of
kEdcat lead to p53 steady-state values well below its homeo-
static set-value p53set. At t ¼ 20 time units kEdcat is decreased
from 1.0  107 to 1.0  106 with ksp53* ¼ ksMdm2* ¼ 0.0,
which leads to an increase in the p53 andMdm2 steady-state
levels. (b) At t¼ 20 time units, kEdcat is decreased from 1.0
106 to 1.0  105 with ksp53* ¼ ksMdm2* ¼ 0.1. Note that
p53 attains now its homeostatic regulated set-value. (c) At
t ¼ 20 time units, kEdcat is decreased from 1.0  106 to
1.0  104 with ksp53* ¼ ksMdm2* ¼ 0.5. Damped harmonic
oscillations in p53 start to emerge around the homeostatic
set-value. (d) At t ¼ 20 time units, kEdcat is decreased from
1.0  106 to 1.0  102 with ksp53* ¼ ksMdm2* ¼ 1.0.
Much less damped harmonic oscillations in p53, p53*,
Mdm2, and Mdm2* are generated (data for p53* and
Mdm2* not shown).
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748 Jolma et al.and kMdm2

s are zero, the system oscillates with the period 2p/
(k $ ks
Mdm2). When kp53

s , and k
Mdm2
s are nonzero, sustained
oscillations are also observed when kp53

d and k
Mdm2
d are zero
and a rapid equilibrium between p53* and p53 as well as
Mdm2* and Mdm2 is established. The period increases as
the rapid equilibrium is shifted more to the p53* and/or
Mdm2* side. If the equilibrium between posttranslationally
modified p53*/Mdm2* and unmodified p53/Mdm2 is slow
compared with the influx of p53, oscillations become
damped.
Fig. 5 shows trajectories of (practically) undamped oscil-
lations in the p53-Mdm2 phase plane with different initial
concentrations. Because the system is harmonic (conserva-
tive), no limit cycle is observed, but parallel trajectories
emerge. In the case in which the trajectories reach the ordi-
nate (Mdm2 axis when p53 ¼ 0), Mdm2 concentrations
decrease until an oscillator with maximum peak amplitude
equal to the p53 set-value emerges (trajectory 5 in Fig. 5).
One may consider such a behavior as a filtering of large
excursions in p53 down to a maximum peak level deter-
mined by p53set.15
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FIGURE 5 Phase plane trajectories of p53-Mdm2 harmonic oscillations
going through three cycles. Rate constants as described in the legend of
Fig. 4. To illustrate that ks
p53 can be chosen without affecting the p53 oscil-
lations around p53set, ks
p53 was set to 11.0, and kEdcat ¼ 1:0  102. For the
sake of simplicity, all ks, r, d
p53* and ks, r, d
Mdm2* rate constants are set to
zero. Dots show different p53 and Mdm2 start concentrations. Because
the system is conservative, parallel trajectories 1–7 emerge from each of
the starting points. Trajectories 1–4 which lie outside of trajectory 5 (which
is tangenting the ordinate at p53 ¼ 0) will hit the ordinate at low p53 levels
and Mdm2 concentrations will decrease until the system emerges as trajec-
tory 5 oscillations, which have the largest peak amplitude equal to the p53
set-value. Trajectories 6 and 7 which start inside of trajectory 5 will not
be altered, and the system oscillates with peak amplitudes lower than the
p53 set-value.
Biophysical Journal 98(5) 743–752The period is not affected by the remaining rate constants.
Note that kEdcat needs to be sufficiently small and K
Ed
M needs to
be sufficiently large to get oscillations, but the period of the
oscillations is not dependent on those values.
Due to the large amplitude variations found for experi-
mentally recorded p53/Mdm2 oscillations (27), we became
interested in the effect of fluctuations on the model. For
this purpose, rate parameters were allowed to vary randomly
and rapidly within a certain range by using the Fortran
routine RAN1 (59). Fig. 6, a and b, shows the variations
in ks
p53 and kEdcat as a function of time (see Supporting Mate-
rial for an overview of all rate parameter variations). Fig. 6 c
shows the behavior of the model compared to experimental
data (Fig. 6 d). The computations show, in agreement with
the experimental observations, that the amplitude of the
oscillations is subject to considerable variation, whereas
the period and the phase relationship between p53 and
Mdm2 are little affected. However, it should be noted that
changes in the average values of k (Eq. 12) or ks
Mdm2 will
lead to period changes, because these two parameters deter-
mine period length (compare with Eq. 5).DISCUSSION
p53 regulation: comparison with experiments
The homeostatic inflow model suggests the need for p53-
regulation to avoid unregulated large p53 levels that would
lead to premature apoptosis. An intriguing aspect of the
p53-Mdm2 regulatory system is the occurrence of oscilla-
tions. There are two major requirements to get oscillations
in the homeostatic inflow model:
1. The need for a relatively strong binding between p53 and
the controller (Mdm2); and
2. That the degradation of p53 by Mdm2-independent
processes (represented in the model by the Ed degradation
pathway) should be low compared to the removal of
newly synthesized p53 by Mdm2 (Eq. 8).
With respect to the first requirement, binding studies have
shown that Mdm2 and p53 can interact by their N-terminal
domains or by Mdm2‘s acid domain and p53’s core domain
(40). The latter binding site appears to be essential for the
ubiquitination of p53 and its degradation. Ma et al. (60)
estimated the dissociation constant (Kd) of this binding site
as well as the KM value of p53 from ubiquitination kinetics.
They concluded that there is a relative high affinity (<1 mM)
between Mdm2 and p53 for this binding site, supporting the
requirement by the homeostatic inflow model. Ma et al.
further conclude that although the individual peptides
derived from the acidic and zinc-finger domain of Mdm2
show a weak affinity toward p53 (40), there may be multiple
contacts to form a specific site with higher affinity in binding
to p53 within the central domain of Mdm2. With respect to
the model’s second requirement, experiments have shown
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FIGURE 6 Rapid fluctuations in rate parameters lead to
variations in the amplitude of the p53/Mdm2 oscillations,
but preserve their period. For the sake of simplicity, all
ks, r, d
p53* and ks, r, d
Mdm2* rate constants are set to zero.
(a and b) Variations for ks
p53 and kEdcat, respectively; see
also Supporting Material. (c) Resulting oscillations in p53
and Mdm2 levels when applying rapid fluctuations for all
rate parameters within the ranges indicated by Table S1 in
the Supporting Material. Rate constant values of k and
ks
Mdm2 have been adjusted such that the period of the
harmonic unperturbed oscillations is close to the experi-
mental value of 5.5 h (27). (d) Observed p53 (solid line)
andMdm2 (dashed line) oscillations in single cells. (Replot-
ted from upper left of Fig. 1 B in Geva-Zatorsky et al. (27).)
Oscillations in Homeostatic Controllers 749that p53 becomes stabilized by a decrease in the Mdm2
stability (43) and by inhibiting Mdm2-independent degrada-
tion pathways (16–21,36,37). Although in the model oscilla-
tions with little damping can be observed when kEdcat is
decreased to 102 a.u. (Fig. 4), kEdcat can practically be set to
zero without significantly altering the oscillations, as long
as there is some synthesis in p53.
The other parameters can be varied within a wide range
during which oscillations can still be observed, and rate
constant values (with timescales in hours, Fig. 6, a–c) can
reflect observed half-lives for p53 and Mdm2 (43,61).
For getting p53 to be homeostatically controlled, Mdm2
(or other p53-degrading factors which constitute a negative
feedback loop with p53) need to be removed by zero-order
kinetics, i.e., at the maximum enzymatic activity for Mdm2
removal (14). It may be that accelerated MDM2 autodegra-
dation (43) is a mechanism to reach maximum (zero-order)
Mdm2 degradation and thus p53 homeostasis.
Due to the harmonic character of the model’s oscillations,
the phase difference between p53 and Mdm2 is given by the
relationship p/2: 2p ¼ 4: P, where P is the period of the
harmonic oscillator in the absence of posttranslational modi-
fications. With an average experimental period of ~6 h (27),
the calculated phase difference is ~1.5 h, which is in good
agreement with the experimentally determined value of
2h 5 0.5h (27). The period length P is dependent on
two rate constants by P ¼ 2p/(k $ kadapt). This relation-
ship is a good approximation. In the presence of posttransla-
tional modifications of p53 and Mdm2, the period increaseswith increasing amounts of p53* and Mdm2*. Assuming
rapid equilibria between p53*/Mdm2* and the respective
unmodified forms p53/Mdm2, in the harmonic limit
kadapt is multiplied by a factor f
p53 ¼ Kp53=ð1þ Kp53 Þ,
with Kp53
 ¼ p53=p53, whereas k is multiplied with a
corresponding factor fMdm2
 ¼ KMdm2=ð1þ KMdm2 Þ with
KMdm2
 ¼ Mdm2=Mdm2. Thus, in this representation of
the p53 regulation the period of the oscillations should
change when the ratio between posttranslationally modified
p53/Mdm2 is altered. The model also implies that the source
of oscillations is the presence of unmodified p53 and Mdm2,
probably due to an undisturbed synthesis (22).
Geva-Zatorsky et al. (27) reported that not all cells show
oscillations but that the fraction of oscillatory cells increase
as the dose of the g-irradiation increases. Our model suggests
that with increasing dose of g-irradiation and the subsequent
lowering of the Mdm2-independent degradation of p53,
oscillations appear when the Mdm2-induced removal of
p53 is zero-order, with respect to p53. The damping of the
oscillations is determined by several factors including the
strength of p53-binding to the p53-degrading protein-
complexes or scaffolds. When this binding is weak, our
model predicts strong damping in the p53/Mdm2 oscilla-
tions, whereas the oscillations should become less damped
when the binding to the p53-degrading protein complexes
is strong. Other factors leading to damping or loss of the
oscillations is a high (Mdm2-independent) p53 degradation
rate and the accumulation of excess posttranslationally
modified p53.Biophysical Journal 98(5) 743–752
750 Jolma et al.Signiﬁcance of zero-order kinetics
Zero-order kinetics appear to be significant in several
respects. In robust homeostatic controllers, zero-order fluxes
define the set-values of (homeostatically) controlled variables
(14), i.e., define the integral feedback (13) necessary for
robust control. In the model presented here, zero-order flux
in the degradation of Mdm2 suggests that p53 may be subject
to robust control, such that its concentration is not able to
exceed an upper boundary limit. This limit (p53set, Eq. 13)
is reached in the presence of DNA damage when the
Mdm2-independent degradation reaction of p53 (16–21) is
inhibited or slowed down bymechanisms still not well under-
stood (Fig. 3). When, in addition to this upregulation of p53,
the p53 reaction order in the Mdm2-mediated removal of p53
is zero due to a strong binding of p53 to its degradation
complex, harmonic oscillations appear, whose peak ampli-
tude is determined by p53set (Fig. 5). Due to the harmonic
character of the oscillations, the amplitude of the p53/
Mdm2 oscillations is quite sensitive to rapid perturbations/
fluctuations similar to experimental observations (Fig. 6).Biological signiﬁcance
Do the oscillations and the large variability in the p53/Mdm2
amplitudes serve a purpose? One possibility may be that the
oscillations represent a counting mechanism by which deci-
sions are made whether DNA repair should be enhanced or
apoptosis should be initiated (62). A higher number of cycles
would favor apoptosis because higher p53 activity/concentra-
tion activates pro-apoptotic genes (63). A periodic activation
of these genes may have the advantage of lowering inhibition
actions at the promoter site or elsewhere—compared to
continuous activation (64). This can be associated with
a significant decrease in the threshold level of radiation at
which the decision from pro-survival to pro-apoptotic state
occurs (51). To make such a decision as unbiased as possible,
the large variability in the p53 amplitudes seem to indicate
that such fluctuations play a role in the p53 decision between
‘‘life and death’’ (46). Another possibility discussed for the
role of oscillations is a longer maintenance of indecisiveness
for a better evaluation of the pros and cons of a decision (26).
Besides defining the set-values of homeostatically con-
trolled variables (14), zero-order reactions are also key
elements in ultrasensitive switches (65–67). Although we
have not considered such switches explicitly here, it is
intriguing that zero-order kinetics can lead to such diverse
behaviors ranging from ultrasensitive switches, relating
homeostatic threshold values to oscillatory responses. It
will be interesting to combine such regulatory motifs in regu-
latory models of biological networks.Comparison with other models
Due to the importance of p53 in the control of DNA integ-
rity, cell cycle arrest, and apoptosis, as well as its relevanceBiophysical Journal 98(5) 743–752for cancer research (48,49), a variety of models for the nega-
tive feedback control of p53 by Mdm2 and its oscillatory
responses have been proposed (27,68–75). In contrast to
the model presented here which shows harmonic oscilla-
tions, other models (27,68,70–74) are based on deterministic
limit cycle oscillations. Several additional oscillator classes
have recently been analyzed by Geva-Zatorsky et al. (27)
and Zhang et al. (70). The model presented here is based
on a homeostatic inflow control mechanism (14) when p53
becomes upregulated. This inflow controller can show
harmonic oscillations, which are suppressed when p53 is
normally at low levels due to several degradation mecha-
nisms (16–21,36,37). Concerning the observed oscillations
in the inflow controller, we are not aware of any molecular
mechanism that has been shown to exhibit large amplitude
harmonic oscillations. It may also be noted that the rapidly
fluctuating molecular noise applied on rate parameters by
RAN1 (Fig. 6, a and b, and Supporting Material) has practi-
cally an infinite period (59) and leads to large variations in
the amplitude of the p53/Mdm2 oscillation (Fig. 6 c) in close
agreement to experimental data (Fig. 6 d). With the excep-
tion of recent stochastic approaches (28,69,75) none of the
deterministic models have presently been able to model the
large variability in amplitude in the presence of rapid molec-
ular fluctuations.
Since the pioneering work of Goodwin (76), many
studies have shown that negative feedback regulation can
lead to oscillations. The Goodwin equations (76) have
been applied to circadian (77) as well as ultradian rhythms
(73). In transcriptional-translational negative feedback regu-
lators the intermediate mRNA species have been recognized
to induce transcriptional time delays, which are important
to generate these oscillations (73). In addition, protein (or
mRNA) stabilities are important determinants for period
length (78,79).
In this model the negative feedback involving the tran-
scriptional and translational processes induced by p53 have
been fused into the single first-order term ks
Mdm2 $ p53
(Eq. 9). This first-order term suggests that binding of p53
at the Mdm2 promoter is relatively weak, where ks
Mdm2
describes the overall expression of Mdm2 under such condi-
tions (see Supporting Material).
The occurrence of large amplitude harmonic oscillations
in cell regulatory networks, such as the oscillations in the
core regulatory unit of the p53/Mdm2 system, appears
intriguing. Similar highly variable amplitude oscillations
with a relatively fixed frequency have been reported in the
SOS DNA-damage response of Escherichia coli (80) and
in the NF-kB system (81–83). Both NF-kB and the SOS
regulation in E. coli are based on negative feedback regula-
tion similar to the p53/Mdm2 system. Whether the variability
in amplitude in the SOS or in NF-kB system can be based on
similar oscillatory dynamics as found for homeostatic
controllers (14) and considered here for the p53/Mdm2
system will be the subject of further investigations.
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